Forte BiosciencesFBRX
13F holders, Q4 2024 (December 31)26holders +2
8new positions
7sold out
$22.71avg. 13F price*
At the end of Q4 2024, 26 institutions reported holding Forte Biosciences Inc. (FBRX) in their 13F filings, up 2 from Q3 2024. 8 opened new positions and 7 sold out. The largest holders were Fred Alger Management, LLC ($25.8M), Tybourne Capital Management (hk) Ltd. ($14.1M) and Ikarian Capital, LLC ($13.8M).
- Company
- Forte Biosciences Inc.
- CUSIP
- 34962G208
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $34.6M |
| Exits | 7 | $510K |
All 13F filers, Q3 2024 → Q4 2024: 3,668,990 shares bought and 129,796 shares sold, net +3,539,194 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Fred Alger Management, LLC | 0.12% | Add +1271.2% | 1,133,944 | $25.8M |
| Tybourne Capital Management (hk) Ltd. | 3.53% | Add +327.6% | 619,981 | $14.1M |
| Ikarian Capital, LLC | 3.95% | New | 609,225 | $13.8M |
| Orbimed Advisors LLC | 0.28% | New | 600,000 | $13.6M |
| BVF Inc. | 0.46% | Add +398.2% | 594,282 | $13.5M |
| Cable Car Capital, LP | 0.38% | Add +170.2% | 219,604 | $5.0M |
| Woodline Partners LP | 0.03% | New | 204,275 | $4.6M |
| Perceptive Advisors LLC | 0.06% | No change | 95,742 | $2.2M |
| Boothbay Fund Management, LLC | 0.06% | New | 89,191 | $2.0M |
| Farallon Capital Management, L.L.C. | 0.00% | Reduce -51.7% | 35,000 | $795K |
| Vanguard Group Inc. | 0.00% | No change | 26,394 | $599K |
| Acuta Capital Partners, LLC | 0.41% | New | 18,139 | $412K |
| Geode Capital Management, LLC | 0.00% | Add +18.3% | 16,877 | $383K |
| BlackRock, Inc. | 0.00% | No change | 6,803 | $154K |
| Royal Bank of Canada | 0.00% | New | 3,784 | $86K |
| JPMorgan Chase & Co. | 0.00% | Add +70000.0% | 2,103 | $48K |
| Morgan Stanley | 0.00% | No change | 151 | $3K |
| Group One Trading LLC | 0.00% | Reduce -81.4% | 104 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -87.6% | 100 | $2K |
| Comerica Bank | 0.00% | New | 56 | $1K |
| Private Trust Co. NA | 0.00% | New | 42 | $954 |
| SBI Securities Co., Ltd. | 0.00% | — | 12 | $273 |
| Bank of America Corp. | 0.00% | Reduce -56.5% | 10 | $227 |
| BNP Paribas Financial Markets | 0.00% | No change | 8 | $182 |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0.00% | No change | 7 | $107 |
| REAP Financial Group, LLC | 0.00% | No change | 3 | $68 |
"% of holder's portfolio" is FBRX's weight in each manager's 13F, not the share of Forte Biosciences Inc. the manager owns.